Gainers
- Clene CLNN shares moved upwards by 54.9% to $0.48 during Tuesday's after-market session. The company's market cap stands at $61.6 million.
- Talphera TLPH shares moved upwards by 11.65% to $1.15. The company's market cap stands at $19.5 million.
- Lexaria Bioscience LEXX stock moved upwards by 8.22% to $2.5. The market value of their outstanding shares is at $32.2 million.
- Cyclacel Pharmaceuticals CYCC stock increased by 7.14% to $1.8. The market value of their outstanding shares is at $2.3 million.
- IGC Pharma IGC shares rose 6.99% to $0.52. The company's market cap stands at $34.3 million.
- SHL Telemedicine SHLT stock increased by 6.94% to $5.39. The market value of their outstanding shares is at $88.3 million.
Losers
- Telesis Bio TBIO shares fell 15.9% to $0.31 during Tuesday's after-market session. The company's market cap stands at $9.2 million.
- Dynatronics DYNT stock decreased by 14.53% to $0.47. The market value of their outstanding shares is at $2.2 million.
- Ontrak OTRK stock decreased by 13.29% to $0.4. The market value of their outstanding shares is at $16.9 million. As per the news, the Q4 earnings report came out today.
- China SXT Pharmaceuticals SXTC stock fell 12.35% to $1.42.
- PaxMedica PXMD shares fell 9.75% to $0.6. The market value of their outstanding shares is at $4.4 million.
- Longeveron LGVN stock declined by 9.35% to $3.2. The company's market cap stands at $10.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
CYCCCyclacel Pharmaceuticals Inc
$0.3561-6.29%
DYNTDynatronics Corp
$0.1409-42.3%
IGCIGC Pharma Inc
--%
LEXXLexaria Bioscience Corp
$1.68-2.75%
LGVNLongeveron Inc
$1.600.63%
OTRKOntrak Inc
$1.66-3.43%
PXMDPaxMedica Inc
$0.0310-%
SHLTSHL Telemedicine Ltd
$2.70-4.93%
SXTCChina SXT Pharmaceuticals Inc
$0.513811.9%
TBIOTelesis Bio Inc
$0.2800-36.4%
TLPHTalphera Inc
$0.74994.30%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in